Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Pathol ; 54(11): 854-9, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11684720

ABSTRACT

AIM: To analyse whether the mean nuclear area of the 10 largest nuclei (MNA-10), the mitotic activity index (MAI), and Ki-67 immunoquantitative features have additional value to discriminate different grades of T(A,1) transitional cell carcinoma (TCC) of the urinary bladder. MATERIALS/METHODS: One hundred and fifty of 200 consecutive cases (75%) showing interobserver agreement on duplicate blind grade assessment by independent pathologists were studied. Using random numbers, the 150 cases were divided into sets for learning (n = 75) and testing (n = 75). Single and multivariate analyses were applied to discriminate the different grades in the learning set. The multivariate classifier developed in this way was evaluated in the test set (n = 75). RESULTS: With the MNA-10 alone, using the classification MNA-10 < 80 microm(2) = grade 1, 80 microm(2) < MNA-10 < 130 microm(2) = grade 2, MNA-10 > 130 microm(2) = grade 3, 71% of all 150 cases were correctly classified (69% of grade 1 v grade 2 and 76% of grade 2 v grade 3). With multivariate analysis, the best discriminating features in the learning set (17 grade 1, 30 grade 2, and 28 grade 3) between grades 1 and 2 were MNA-10 and MAI, and between grades 2 and 3 MAI and Ki-67. With these features, 94% of grade 1 v grade 2 and 97% of grade 2 v grade 3 were correctly classified in the learning set (overall, 95% correct, none of the grade 3 cases misclassified). In the test set the classification results were similar. When the three grades were entered at the same time for discrimination, Ki-67 area % and MAI was the best discriminating combination, both in the sets for learning and testing. Overall correct classification results in the sets for learning and testing were slightly lower, but still 94% and 92%. Most importantly, none of the grade 3 cases was misclassified; the classification shifts all occurred between grades 1 and 2. CONCLUSIONS: The combination of MNA-10, MAI, and Ki-67 gives much better discrimination between grades 1, 2, and 3 in T(A,1) TCC of the urinary bladder than MNA-10 alone. The similarity of the classification results of the learning set and test set are encouraging and this quantitative pathological grading model should be applied in a prospective study.


Subject(s)
Carcinoma, Transitional Cell/pathology , Urinary Bladder Neoplasms/pathology , Aged , Biomarkers, Tumor/analysis , Carcinoma, Transitional Cell/immunology , Cell Nucleus/ultrastructure , Humans , Immunohistochemistry , Ki-67 Antigen/analysis , Middle Aged , Mitotic Index , Multivariate Analysis , Predictive Value of Tests , Urinary Bladder Neoplasms/immunology
2.
J Urol ; 146(4): 1113-4, 1991 Oct.
Article in English | MEDLINE | ID: mdl-1895435

ABSTRACT

Two patients with histologically confirmed interstitial cystitis underwent bladder augmentation procedures (clam cystoplasty and Mainz pouch cystoplasty) because of therapy resistant low abdominal pain and decreased functional bladder capacity. However, symptoms of low abdominal pain and urinary retention (1 patient) persisted, and cystectomy was performed in both patients after 14 and 20 months, respectively. Histological examination of the specimens showed changes in the intestinal areas of the augmented bladder, resembling interstitial cystitis. The etiology of this phenomenon and the possible role of intestinal interstitial cystitis in augmentation failures are discussed.


Subject(s)
Cystitis/pathology , Mast Cells/pathology , Urinary Bladder/pathology , Adult , Cystectomy , Cystitis/surgery , Female , Humans , Ileum/pathology , Ileum/surgery , Middle Aged , Reoperation , Urinary Bladder/surgery , Urinary Diversion
3.
Eur Urol ; 18(4): 299-301, 1990.
Article in English | MEDLINE | ID: mdl-2127019

ABSTRACT

Changes in testicular morphology are quantified in patients with metastatic prostatic cancer, treated with LHRH agonist Buserelin and compared with testes of young transsexuals and patients with metastatic prostatic cancer treated with orchidectomy only. No significant changes within 18 months were seen, suggesting reversibility of LHRH agonist effects on testicular morphology in this time period. Histomorphometrics of the testis are useful to quantify these changes.


Subject(s)
Buserelin/adverse effects , Prostatic Neoplasms/drug therapy , Testis/drug effects , Adult , Aged , Aged, 80 and over , Buserelin/therapeutic use , Humans , Leydig Cells/drug effects , Male , Middle Aged , Spermatogenesis/drug effects , Testis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...